Dr. T. Clark Gamblin

Dr. T. Clark Gamblin, MD, MS, MBA, is a nationally recognized surgical oncologist specializing in hepatopancreatobiliary malignancies, with a particular focus on liver cancer. He serves as the Chief of Surgical Oncology and the Robert and Suzanne T. Haney Professor of Surgical Oncology at the Medical College of Wisconsin and Froedtert Hospital. Dr. Gamblin earned his medical degree from the University of Connecticut School of Medicine, completed his residency in general surgery at the University of Connecticut, and pursued fellowship training in surgical oncology at the University of Pittsburgh Medical Center. He is board-certified in General Surgery and is widely regarded for his leadership in hepatobiliary surgery and liver cancer clinical research.

A leader in surgical oncology, Dr. Gamblin has pioneered surgical techniques and clinical strategies to improve outcomes in liver cancer, cholangiocarcinoma, and metastatic colorectal cancer to the liver. His research program integrates surgical innovation, clinical trials, and translational science, and he has authored more than 200 peer-reviewed publications. He has been actively involved in developing national and international guidelines for liver-directed therapies and hepatobiliary cancer surgery.

In addition to his surgical and research leadership, Dr. Gamblin is a dedicated mentor and educator, training surgical oncology fellows and residents. He has served in leadership positions within the American Hepato-Pancreato-Biliary Association and the Society of Surgical Oncology. Through his clinical expertise, research innovation, and mentorship, Dr. T. Clark Gamblin continues to influence the field of hepatobiliary oncology and improve surgical outcomes for patients with complex liver cancers.